Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN Guidelines Journal Article
| Authors: | Daly, M. B.; Pilarski, R.; Berry, M.; Buys, S. S.; Farmer, M.; Friedman, S.; Garber, J. E.; Kauff, N. D.; Khan, S.; Klein, C.; Kohlmann, W.; Kurian, A.; Litton, J. K.; Madlensky, L.; Merajver, S. D.; Offit, K.; Pal, T.; Reiser, G.; Shannon, K. M.; Swisher, E.; Vinayak, S.; Voian, N. C.; Weitzel, J. N.; Wick, M. J.; Wiesner, G. L.; Dwyer, M.; Darlow, S. |
| Article Title: | Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN Guidelines |
| Abstract: | The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer. © JNCCN-Journal of the National Comprehensive Cancer Network. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 15 |
| Issue: | 1 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2017-01-01 |
| Start Page: | 9 |
| End Page: | 20 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 28040716 |
| DOI: | 10.6004/jnccn.2017.0003 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 February 2017 -- Source: Scopus |
